首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity
【24h】

Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity

机译:人脂肪干细胞的长期体外扩增显示出致瘤性的风险低

获取原文
获取原文并翻译 | 示例
           

摘要

In the field of cell-based therapy and regenerative medicine, clinical application is the ultimate goal. However, one major concern is: does in vitro manipulation during culture expansion increases tumourigenicity risk on the prepared cells? Therefore, the aim of this study was to investigate the effect of long-term in vitro expansion on human adipose-derived stem cells (ASCs). The ASCs were harvested from lipo-aspirate samples and cultured until passage 20 (P20), using standard culture procedures. ASCs at P5, P10, P15 and P20 were analysed for morphological changes, DNA damage (Comet assay), tumour suppressor gene expression level (quantitative PCR), p53 mutation, telomerase activity, telomere length determination and in vivo tumourigenicity test. Our data showed that ASCs lost their fibroblastic feature in long-term culture. The population doubling time of ASCs increased with long-term culture especially at P15 and P20. There was an increase in DNA damage at later passages (P15 and P20). No significant changes were observed in both p53 and p21 genes expression throughout the long-term culture. There was also no p53 mutation detected and no significant changes were recorded in the relative telomerase activity (RTA) and mean telomere length (TRF) in ASCs at all passages. In vivo implantation of ASCs at P15 and P20 into the nude mice did not result in tumour formation after 4 months. The data showed that ASCs have low risk of tumourigenicity up to P20, with a total population doubling of 42 times. This indicates that adipose tissue should be a safe source of stem cells for cell-based therapy.
机译:在基于细胞的治疗和再生医学领域,临床应用是最终目标。但是,一个主要问题是:培养扩增过程中的体外操作是否会增加所制备细胞的致瘤性风险?因此,本研究的目的是研究长期体外扩增对人脂肪干细胞(ASCs)的影响。从吸脂样品中收集ASC,并使用标准培养程序培养至第20代(P20)。分析了P5,P10,P15和P20的ASC的形态学变化,DNA损伤(Comet分析),抑癌基因表达水平(定量PCR),p53突变,端粒酶活性,端粒长度测定和体内致瘤性测试。我们的数据表明,ASC在长期培养中丧失了成纤维细胞特征。长期培养尤其是在P15和P20时,ASC的种群倍增时间增加。后来的传代(P15和P20)DNA损伤增加。在整个长期培养过程中,p53和p21基因表达均未见明显变化。在所有传代中,也没有检测到p53突变,并且在ASC中的相对端粒酶活性(RTA)和端粒平均长度(TRF)没有明显变化。在P15和P20将ASC体内植入裸鼠后4个月后未导致肿瘤形成。数据显示,ASCs到P20为止具有较低的致瘤性风险,总人口增加了42倍。这表明脂肪组织应该是基于细胞疗法的安全干细胞来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号